GleamWall
中文EN

NVAX NOVAVAX INC

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1000694 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-61.3%
TTM net income YoY-122.5%
TTM EPS YoY-125.9%
Revenue 3-yr CAGR-26.8%
Net income 3-yr CAGR—

Margins

Gross margin78.0%
Operating margin-21.2%
Net margin-18.6%
FCF margin-59.2%
EBITDA margin-17.7%

Returns

ROE—
ROA-7.4%
ROIC (approx.)—
Asset turnover0.40x

Leverage & solvency

Liabilities / assets124.4%
Debt / equity—
Current ratio2.15x
Interest coverage-4.01x

Cash quality & payout

Operating cash flow / net income3.11x
Accruals ratio15.7%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.12B$682.16M
Cost of revenue$73.04M$202.74M
Gross profit$1.05B$479.42M
R&D expense$342.32M$391.17M
SG&A expense$157.48M$337.19M
Operating income$452.80M-$248.93M
Interest expense$22.55M$20.07M
Pretax income$442.17M-$176.62M
Income tax$1.86M$10.88M
Net income$440.30M-$187.50M
EBITDA$480.80M-$200.93M
EPS (basic)2.72-1.23
EPS (diluted)2.58-1.23
Weighted avg. shares (diluted)173.10M152.19M
Balance sheet
Cash & equivalents$240.63M$545.29M
Short-term investments$494.45M$392.89M
Inventory$11.54M$8.75M
Current assets$978.28M$1.13B
PP&E, net$44.80M$138.41M
Goodwill$113.46M$107.48M
Total assets$1.18B$1.56B
Current liabilities$459.95M$1.15B
Long-term debt$244.21M—
Total debt$244.21M—
Total liabilities$1.30B$2.18B
Shareholders' equity-$127.75M-$623.84M
Net debt$3.58M—
Shares outstanding162.58M160.42M
Cash flow statement
Operating cash flow-$244.63M-$87.26M
Capital expenditure$5.56M$13.06M
Free cash flow-$250.19M-$100.32M
Investing cash flow-$78.27M-$204.04M
Financing cash flow$27.74M$260.58M
Depreciation & amortization$28.00M$48.00M
Stock-based compensation$36.02M$48.15M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.